Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

633 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.
Mavroudis D, Malamos N, Alexopoulos A, Kourousis C, Agelaki S, Sarra E, Potamianou A, Kosmas C, Rigatos G, Giannakakis T, Kalbakis K, Apostolaki F, Vlachonicolis J, Kakolyris S, Samonis G, Georgoulias V. Mavroudis D, et al. Among authors: georgoulias v. Ann Oncol. 1999 Feb;10(2):211-5. doi: 10.1023/a:1008315723253. Ann Oncol. 1999. PMID: 10093691 Free article. Clinical Trial.
Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: a multicenter dose-escalation study. The Greek Breast Cancer Cooperative Group (GBCCG).
Kouroussis C, Xydakis E, Potamianou A, Giannakakis T, Kakolyris S, Agelaki S, Sara E, Malamos N, Alexopoulos A, Mavroudis D, Samonis G, Papadouris S, Georgoulias V, Panagos G. Kouroussis C, et al. Among authors: georgoulias v. Ann Oncol. 1999 May;10(5):547-52. doi: 10.1023/a:1026441804889. Ann Oncol. 1999. PMID: 10416004 Free article. Clinical Trial.
Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: a phase II study.
Kouroussis C, Souglakos J, Kakolyris S, Mavroudis D, Malamos N, Kalbakis K, Androulakis N, Agelaki A, Vardakis N, Samonis G, Georgoulias V. Kouroussis C, et al. Among authors: georgoulias v. Oncology. 2001;61(1):36-41. doi: 10.1159/000055350. Oncology. 2001. PMID: 11474246 Clinical Trial.
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study.
Alexopoulos A, Kouroussis C, Malamos N, Kakolyris S, Kalbakis K, Kosmas C, Mavroudis D, Agelaki S, Vlachonicolis J, Sarra E, Rigatos G, Georgoulias V. Alexopoulos A, et al. Among authors: georgoulias v. Ann Oncol. 2001 Jun;12(6):793-8. doi: 10.1023/a:1011180605373. Ann Oncol. 2001. PMID: 11484954 Free article. Clinical Trial.
Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Kouroussis Ch, Apostolaki S, Malamos N, Kakolyris S, Kotsakis A, Xenidis N, Reppa D, Georgoulias V. Stathopoulou A, et al. Among authors: georgoulias v. J Clin Oncol. 2002 Aug 15;20(16):3404-12. doi: 10.1200/JCO.2002.08.135. J Clin Oncol. 2002. PMID: 12177100
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
Xenidis N, Vlachonikolis I, Mavroudis D, Perraki M, Stathopoulou A, Malamos N, Kouroussis C, Kakolyris S, Apostolaki S, Vardakis N, Lianidou E, Georgoulias V. Xenidis N, et al. Among authors: georgoulias v. Ann Oncol. 2003 Jun;14(6):849-55. doi: 10.1093/annonc/mdg259. Ann Oncol. 2003. PMID: 12796021 Free article.
633 results